Hello, this is Cameron Sabbat with Cutting to the Case, and today we're joined by Dr. Robert Langer. He's an Institute Professor at MIT, the university's highest faculty distinction, held by only a handful of professors, and one of the most influential biomedical inventors in history. He pioneered controlled drug delivery and helped lay the foundations of tissue engineering, and has authored more than 1,600 papers and holds more than 1,500 issued or pending patents. His technologies have been licensed to more than 400 companies, and he's helped found dozens of biotechnology companies, including Moderna.
He's also trained hundreds of scientists and entrepreneurs, creating what has become known as the Langer Tree, a network of former trainees who have gone on to found companies and lead laboratories around the world. His honors include both the U.S. National Medal of Science and National Medal of Technology and Innovation, the Queen Elizabeth Prize for Engineering, the Breakthrough Prize, Kyoto Prize, and Millennium Technology Prize. Dr. Langer, thank you so much for joining us today.
Thank you. So, I'm curious. We only have a little bit of time here. When you're looking at medicine today, where do you see the biggest opportunities that we're all still missing?
Well, I always think it's what hasn't been doesn't have a name because it hasn't been discovered yet. You know, it's interesting. I mean, if you look at gene editing and CRISPR, which is the way that a lot of people edit genes, you know, if you asked somebody about that question, you know, about 14, 15 years ago, and you know, they would have said, well, CRISPR, that has to do with cooking, you know. But now, of course, it's become very, very important as a way of inserting genes, and that certainly is one of the big areas for today. But I think what's great about basic research is that sometimes people will discover things intentionally or unintentionally that can change the world and can change the future of medicine. And so I think that there are things that we don't know yet.
Now, the areas that we do know and certainly will people will continue to make advances are genetic therapies like gene editing, messenger RNA, you know, ways of turning genes on and off. And then I also think cellular therapies, whether they be engineered cells to treat cancer like CAR T cells or regenerative medicine approaches, you know, which can affect longevity and make new tissues and organs, and even organs and tissues on a chip. So there's a lot, a lot of things that are going on that are very exciting.
Absolutely. And you know, from all of these insights that you've had, you've helped build dozens of biotechnology companies. What have you learned about turning a scientific discovery into a company that actually succeeds?
It's a team effort. You know, it's one thing to discover something and make an invention. It's very, very different to really get it out to the world. And it takes a real team. It takes great scientists, but it also takes great business people, great investors, people that can do manufacturing, people that are clinicians, and that team has to work together. And it's a struggle. It's very, very hard because there's many challenges. Anything along the way can stop you. And certainly medicine is not, you know, medical research is not cheap. So, but it's incredibly important because it, you know, it saves, you know, billions of lives.
And speaking of teamwork, you've met and trained thousands of brilliant people. What separates, in your mind, the ones who actually change the world from the people who are merely extremely intelligent?
Well, I think it's never giving up. I think it's laser kind of focus. It's being willing to walk through walls when there, you know, are issues. And it's, you know, really a passion, you know, to really want to do something that'll make a giant difference.
And, you know, there's passion and there's walking through walls, but you've had ideas that experts initially thought were impossible. How do you tell the difference between being ahead of everyone else and simply being wrong?
Yeah. Well, that's a challenge. You know, sometimes it's a judgment call. And you know, it also depends on what data you really have, whether somebody is telling you you're wrong because they're jealous or opinionated, or whether they really have good evidence that you're wrong. You know, and I think it's important. When people told me I was wrong, I always listened. But I, sorry, not to. But you know, I think that I had certainly seen the data that we had, and it certainly made sense to me, and I felt it was theoretically possible regardless of what people said.
And how do you build a company around a technology when the market for that technology doesn't really exist yet?
Well, so the question is how do you build a company around a technology when the market for that technology doesn't really exist yet?
Yeah. Well, that's a very good question. You know, there was a guy, was it Clayton Christensen, who wrote, you know, called The Innovator's Dilemma. He wrote a book called that. And that's, but his point was that that was what you wanted to do was a lot of times the things that have been most successful, the market didn't exist. But you created that market because of that discovery. And so I think, how do you do it? I think it's like you realize, even if other people don't, that maybe what you've done to create opportunities that never existed before, but they couldn't exist because that discovery or invention hadn't been made. And then you think through how that can make the biggest difference now.
Yeah. Yes. And when you think about, you know, Moderna, for instance, what did the creation of Moderna teach you about building a company around a technology that still had enormous scientific uncertainty?
Yeah. Well, Moderna, you know, that again is a great example of a team effort. You know, we had a great CEO, Stéphane Bancel, chairman Nubar Beyen, you know, who was an investor in it as well, and just great scientists. You know, Melissa Moore, Stephen Hoge, you know, Carrie Brodard, we had lots of just great people. A lot of my students, you know, I think it just, and people worked around the clock, you know, when the COVID thing happened, they were working round the clock because they felt that they could make a giant difference. And I think that, you know, that people felt that we all felt that we were doing something very, very important. And I think when you're doing something, you feel that the research you're doing is very important, then people band together and they solve problems.
Yes. And it all really comes back to teamwork, and teamwork helps you spot those opportunities. When you look at medicine today, where do you see the biggest opportunities that we're still missing?
Well, I think a lot of it really comes down to basic science and understanding things better. You know, I don't think we understand. I mean, there's certainly a lot we don't know about cancer, you know, about why a cell becomes cancerous and how you can control that whole thing. There's a lot we don't know about the brain, and if we could, that might teach us how to stop diseases like Alzheimer's and others. So I think a lot does come down to the basic biology about what causes the abnormalities that we have. And so I think a lot of it's basic science, and then the rest of it is technologies. I mean, you know, technologies can make a giant difference. You know, better delivery systems, better imaging techniques, you know, all kinds of things like that, ways to target drugs to specific cells in the body.